Stamford, CT -- (SBWIRE) -- 10/26/2013 -- Jet Life Penny Stocks provides investors with the some of the most Awesome Penny Stock alerts on a regular basis. We will send you alerts through our Penny Stock Newsletter and offer you the tools to help you along the way with the goal of keeping you loyal to our service. Here are some trending Stocks in focus: ARMOUR Residential REIT, Inc.(NYSE:ARR), Opexa Therapeutics Inc(NASDAQ:OPXA), Merck & Co., Inc.(NYSE:MRK), Halcon Resources Corp(NYSE:HK)
ARMOUR Residential REIT, Inc.(NYSE:ARR) stock is at $4.41, down -0.45 percent from its previous close of $4.41. The stock opened the session at $4.45 and touched its highest price point at $4.46. ARMOUR Residential REIT stock’s lowest price point for the session stood at $4.38. Stocks graphical chart shows a bullish trend during its last one month’s trading session. It remained negative -1.56% during the previous three months trade. Its total trading volume is 5.44 million shares for the day, in comparison to its average trading volume of 5.01 million shares. ARMOUR Residential REIT, Inc.( ARMOUR) is an externally-managed Maryland corporation managed by ARMOUR Residential REIT, Inc. The Company invests primarily in hybrid adjustable rate, adjustable rate and fixed rate residential mortgage backed securities (RMBS).
Has ARR Found The Bottom and Ready To Move Up? Find Out Here
Opexa Therapeutics Inc(NASDAQ:OPXA) stock is at $2.07, up +4.81 percent from its previous close of $1.98. Its today’s volume is 1.49 million shares, in comparison to its average trading volume of 927,397.00 shares. The stock opened the session at $1.95 and touched its highest price point at $2.17. Opexa Therapeutics’s lowest price point for the session stood at $1.95 and its 52 week price range stood at $1.07 - $5.19. The company has a total of 22.73 million outstanding shares and its total market capitalization is $47.05 million. Its beta value stands at 1.19 times and earnings per share was $-1.71. Opexa Therapeutics, Inc., a biopharmaceutical company, develops personalized cellular therapies to treat multiple sclerosis (MS) based on its proprietary T-cell technology. Its leading therapy candidate includes Tcelna, a novel T-cell immunotherapy, which is in Phase IIb clinical development for the treatment of patients with secondary progressive MS.
For How Long OPXA will fight for Profitability? Read This Trend Analysis report
Merck & Co., Inc.(NYSE:MRK) opened the session at $46.25 and remained in the $45.85 to $46.58 price range during the session. The stock is +0.69 percent higher at $46.54. Volume closed the day at 17.89 million shares, its average volume being 14.04 million shares. The company has a total of 2.93 billion outstanding shares and its total market capitalization is $136.19 billion. Its beta value stands at 0.35 times and earnings per share was $1.68. MRK was a loser in the 5 days activity and slipped about -0.15%. The one month performance of the stock was negative and it plunged more than -2.37%. Merck & Co., Inc. provides various health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products worldwide.
Will MRK Continue To Move Higher? Find Out Here
Halcon Resources Corp(NYSE:HK) percentage change mounted +0.56%, to close at $5.42 with the total traded volume of 5.19 million shares, less than average volume of 5.84 million. Company’s year to date performance remained declining as it almost -20.76%. If we look at the last 6 months of trade, that is in the bearish zone with a drop of -17.88%. The 52-week price range of the stock remained $4.41 - $8.28, while during last trade its minimum price was $5.32 and it gained its highest price of $5.54. Halcón Resources Corporation, an independent energy company, engages in the acquisition, production, exploration, and development of onshore oil and natural gas properties in the United States.
Why Should Investors Buy HK After The Recent Gain? Just Go Here and Find Out
Jet Life Penny Stocks is always searching the market every day for massive penny stock runs before they happen so you don't have to. Jet Life Penny Stocks also offers free Highly-Professional Grade stock charts and video charts from one of the most experienced and well-respected chartists in the penny stock industry.
Jet Life Penny Stocks is not a registered securities advisor. Investors should always conduct their own additional due diligence with any potential investment or highlighted company. The company provides information on highlighted stocks via press releases, newsletters and company website, but this should not be construed as a recommendation to buy or sell. Please visit the company website for a more complete list of risks and disclosures.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)